“Inflammasomes As a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature”. Principles and Practice of Clinical Research 9, no. 2 (September 3, 2023). Accessed April 17, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/265.